Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 28,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
The Cost Accountant/Operations Finance Analyst will work directly with the Finance Manager and demonstrate initiative and technical competence to handle duties related to the month-end closing, annual audit, financial reporting, reconciliations and analysis for the Finance Department.
This role works closely with the Operations team and will be the primary finance contact for the Operations team.